GENEVA, Aug. 31 -- BOEHRINGER INGELHEIM INTERNATIONAL GMBH filed a patent application (EP2026/054438) for “ANTI-INTERLEUKIN-11 ANTIBODIES AND METHODS OF USE THEREOF”. With publication no. WO/2026/175919, here are the other details related to the patent application:
Kind: Initial Publication without ISR [A2]
IPC: C07K 16/24
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....